Serum soluble VSIG4 as a surrogate marker for the diagnosis of lymphoma-associated hemophagocytic lymphohistiocytosis.

导出 LinkOut

翻译打印收藏纠错

第一作者： Shunzong,Yuan

第一单位： Department of Laboratory Medicine, The Fifth Medical Center, Chinese PLA General Hospital (Former 307th hospital of the PLA), Beijing, China.

作者： Shunzong,Yuan ^[1] ; Yanqing,Wang ^[2] ; Hui,Luo ^[3] ; Zheng,Jiang ^[4] ; Bing,Qiao ^[1] ; Yan,Jiang ^[2] ; Yaning,Hu ^[1] ; Yang,Cheng ^[1] ; Xilin,Chen ^[2] ; Weihua,Gong ^[5] ; Yong,Huang ^[6] ; Weipeng,Zhao ^[7] ; Deyan,Luo ^[8] ; Bing,Liu ^[4] ; Hang,Su ^[2] ; Jianfeng,Zhou ^[3] ; Shiping,Song ^[1]

作者单位： Department of Laboratory Medicine, The Fifth Medical Center, Chinese PLA General Hospital (Former 307th hospital of the PLA), Beijing, China. ^[1] Department of Lymphoma, Head and Neck Cancer, The Fifth Medical Center, Chinese PLA General Hospital (Former 307th hospital of the PLA), Beijing, China. ^[2] Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China. ^[3] Laboratory of Oncology, The Fifth Medical Center, Chinese PLA General Hospital (Former 307th hospital of the PLA), Beijing, China. ^[4] Department of Surgery, Second Affiliated Hospital of School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China. ^[5] Department of Pathology, The PLA 81st Group Army Hospital, Zhangjiakou, China. ^[6] Department of Breast Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China. ^[7] Beijing Institute of Microbiology and Epidemiology, Beijing, China. ^[8]

关键词 VSIG4 biomarker haemophagocytic lymphohistiocytosis lymphoma macrophage